As of 2026-04-03, the Intrinsic Value of Sinsin Pharmaceutical Co Ltd (002800.KQ) is 14,991.83 KRW. This 002800.KQ valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 5,570.00 KRW, the upside of Sinsin Pharmaceutical Co Ltd is 169.20%.
The range of the Intrinsic Value is 9,299.25 - 31,971.15 KRW
Based on its market price of 5,570.00 KRW and our intrinsic valuation, Sinsin Pharmaceutical Co Ltd (002800.KQ) is undervalued by 169.20%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 9,299.25 - 31,971.15 | 14,991.83 | 169.2% |
| DCF (Growth 10y) | 15,317.70 - 46,684.43 | 23,222.54 | 316.9% |
| DCF (EBITDA 5y) | 4,964.29 - 8,050.82 | 6,181.15 | 11.0% |
| DCF (EBITDA 10y) | 9,245.89 - 13,720.19 | 11,032.33 | 98.1% |
| Fair Value | 2,142.78 - 2,142.78 | 2,142.78 | -61.53% |
| P/E | 2,732.09 - 5,211.25 | 4,254.34 | -23.6% |
| EV/EBITDA | 715.80 - 3,378.91 | 1,895.82 | -66.0% |
| EPV | 2,844.16 - 4,337.93 | 3,591.04 | -35.5% |
| DDM - Stable | 5,034.33 - 17,298.58 | 11,166.45 | 100.5% |
| DDM - Multi | 10,040.70 - 26,373.90 | 14,491.43 | 160.2% |
| Market Cap (mil) | 84,496.90 |
| Beta | -0.05 |
| Outstanding shares (mil) | 15.17 |
| Enterprise Value (mil) | 127,310.30 |
| Market risk premium | 5.82% |
| Cost of Equity | 6.09% |
| Cost of Debt | 4.25% |
| WACC | 5.23% |